News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results>BILIBILI-W 4Q25 Adj. NP Leaps 93.8% to RMB878M; US Shrs Leap 3.2% Pre-mkt
BILIBILI-W (09626.HK) announced its results for the last quarter ending December 2025. The total net revenues increased by 7.6% YoY to RMB8.321 billion. Gross profit rose by 10.5% ...
Reset
Send
The window will close in 5 seconds
<Results>BILIBILI-W 4Q25 Adj. NP Leaps 93.8% to RMB878M; US Shrs Leap 3.2% Pre-mkt
Close
Recommend
12
Positive
16
Negative
13
 
 

BILIBILI-W (09626.HK)  +3.800 (+2.868%)    Short selling $230.69M; Ratio 22.341%   announced its results for the last quarter ending December 2025. The total net revenues increased by 7.6% YoY to RMB8.321 billion. Gross profit rose by 10.5% to RMB3.081 billion.

Dividend History
Announce DateEventParticular
2025/11/133rd QuarterlyNo Dividend
2025/08/21InterimNo Dividend
2025/05/201st QuarterlyNo Dividend
2025/02/20FinalNo Dividend

Net profit surged 4.7 times to RMB513 million, with net earnings per share of RMB1.23. On a non-GAAP basis, adjusted net profit for the last quarter spiked by 93.8% to RMB878 million, with adjusted earnings per share of RMB2.1.

Related News JPM: BILIBILI-W (09626.HK) Outlook Positive, Expects Operating Profit to Rise 23% This Year
Bilibili (BILI.US)      soared 3.2% pre-market in US trading at USD28.39.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-29 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.